X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (1171) 1171
animals (1065) 1065
ergolines - pharmacology (1023) 1023
humans (889) 889
female (850) 850
rats (755) 755
ergolines - therapeutic use (563) 563
adult (462) 462
quinpirole (460) 460
ergolines - administration & dosage (436) 436
middle aged (367) 367
rats, inbred strains (308) 308
cabergoline (293) 293
pharmacology & pharmacy (290) 290
dose-response relationship, drug (287) 287
prolactin - blood (263) 263
receptors, dopamine - drug effects (257) 257
index medicus (243) 243
dopamine (237) 237
aged (233) 233
neurosciences (231) 231
dopamine agents - pharmacology (227) 227
dopamine agonists - therapeutic use (221) 221
endocrinology & metabolism (221) 221
ergolines - adverse effects (217) 217
pregnancy (202) 202
time factors (197) 197
parkinson disease - drug therapy (187) 187
2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine - pharmacology (178) 178
benzazepines - pharmacology (177) 177
dopamine agonists - pharmacology (165) 165
motor activity - drug effects (160) 160
pituitary neoplasms - drug therapy (157) 157
bromocriptine - therapeutic use (155) 155
apomorphine - pharmacology (152) 152
bromocriptine (146) 146
behavior, animal - drug effects (136) 136
mice (134) 134
dopamine agonists - administration & dosage (130) 130
prolactin (129) 129
rats, sprague-dawley (126) 126
dopamine agonists (125) 125
prolactinoma - drug therapy (123) 123
receptors, dopamine - physiology (115) 115
receptors, dopamine d2 (115) 115
bromocriptine - pharmacology (114) 114
pergolide (110) 110
drug therapy, combination (103) 103
treatment outcome (102) 102
clinical neurology (99) 99
dopamine - metabolism (99) 99
dopamine - physiology (97) 97
corpus striatum - drug effects (96) 96
stereotyped behavior - drug effects (96) 96
bromocriptine - administration & dosage (94) 94
dopamine agonists - adverse effects (93) 93
adolescent (91) 91
hyperprolactinemia - drug therapy (90) 90
sulpiride - pharmacology (90) 90
rats, wistar (89) 89
administration, oral (85) 85
dopamine antagonists (84) 84
receptors (83) 83
haloperidol - pharmacology (82) 82
hyperprolactinemia (82) 82
parkinson's disease (82) 82
rat (82) 82
2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1h-3-benzazepine (81) 81
apomorphine (81) 81
corpus striatum - metabolism (81) 81
dopamine agonist (80) 80
lisuride - pharmacology (77) 77
receptors, dopamine d1 (76) 76
lisuride - administration & dosage (75) 75
drug administration schedule (73) 73
serotonin antagonists - pharmacology (73) 73
antineoplastic agents - therapeutic use (71) 71
clinical trials as topic (71) 71
dogs (71) 71
medicine & public health (71) 71
brain - drug effects (70) 70
receptors, dopamine d2 - drug effects (70) 70
drug interactions (69) 69
levodopa - therapeutic use (68) 68
brain (67) 67
parkinsons-disease (67) 67
blood pressure - drug effects (66) 66
magnetic resonance imaging (66) 66
prolactin - metabolism (66) 66
agonists (65) 65
brain - metabolism (64) 64
lisuride - therapeutic use (63) 63
double-blind method (62) 62
prolactinoma (62) 62
receptor (62) 62
bromocriptine - adverse effects (61) 61
dopamine receptors (61) 61
levodopa - administration & dosage (61) 61
acromegaly - drug therapy (60) 60
therapy (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1761) 1761
French (30) 30
German (22) 22
Japanese (22) 22
Italian (19) 19
Russian (18) 18
Spanish (16) 16
Czech (7) 7
Bulgarian (4) 4
Danish (2) 2
Hungarian (2) 2
Dutch (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Molecular Sciences, ISSN 1661-6596, 12/2017, Volume 18, Issue 12, p. 2586
Uterine fibroids (UFs) are the most common tumors of the female genital tract. The effect of UFs on the quality of life and the overall cost of treatment are... 
Leiomyoma | Uterine fibroid | Epigallocatechin gallate | Vitamin D | Paricalcitol | Pharmacology | Cabergoline | Elagolix | Aromatase inhibitors | AROMATASE INHIBITOR LETROZOLE | paricalcitol | epigallocatechin gallate | elagolix | MEDICAL-MANAGEMENT | GREEN TEA POLYPHENOLS | vitamin D | BIOCHEMISTRY & MOLECULAR BIOLOGY | CABERGOLINE DOSTINEX | aromatase inhibitors | cabergoline | VITAMIN-D DEFICIENCY | CHEMISTRY, MULTIDISCIPLINARY | uterine fibroid | pharmacology | CARDIOVASCULAR-DISEASE | LEIOMYOMA CELL-PROLIFERATION | EXTRACELLULAR-MATRIX | TRANSFORMING GROWTH FACTOR-BETA-3 | leiomyoma | Aromatase Inhibitors - administration & dosage | Ergolines - administration & dosage | Administration, Oral | Pyrimidines - administration & dosage | Humans | Catechin - administration & dosage | Ergocalciferols - therapeutic use | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Ergolines - therapeutic use | Hydrocarbons, Fluorinated - administration & dosage | Pyrimidines - therapeutic use | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Quality of Life | Catechin - therapeutic use | Ergocalciferols - administration & dosage | Female | Vitamin D - administration & dosage | Catechin - analogs & derivatives | Hydrocarbons, Fluorinated - therapeutic use | Vitamin D - therapeutic use | Aromatase Inhibitors - therapeutic use | Genital tract | Risk groups | Prophylaxis | Epigallocatechin-3-gallate | Hysterectomy | Modulators | Quality of life | Uterus | Surgery | Aromatase | Progesterone | Tumors
Journal Article
Movement Disorders, ISSN 0885-3185, 11/2004, Volume 19, Issue 11, pp. 1370 - 1374
Journal Article
Journal Article
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 04/2012, Volume 97, Issue 4, pp. 1303 - 1310
Journal Article
Internal Medicine, ISSN 0918-2918, 2013, Volume 52, Issue 3, pp. 325 - 332
Journal Article
Journal of Neurology, ISSN 0340-5354, 05/2009, Volume 256, Issue 5, pp. 816 - 819
Journal Article
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 06/2015, Volume 172, Issue 6, pp. 707 - 713
Journal Article